-
Product Insights
Ochsner Health – Robert J. and Debra H. Patrick Neuroscience Center – Louisiana
The Ochsner Health – Robert J. and Debra H. Patrick Neuroscience Center – Louisiana project involves the construction of a 12,263m2 neuroscience center in New Orleans, Louisiana, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Ochsner Health – Robert J. and Debra H. Patrick Neuroscience Center – Louisiana report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Epidermolysis Bullosa Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Epidermolysis Bullosa Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Epidermolysis Bullosa Clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Product Insights
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H2, 2017" provides an overview of Epidermolysis Bullosa clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Country Profile: Meat sector in Belgium
Belgium’s Meat sector accounted for a 0.7% value share of the global sector in 2016. In the Western Europe region, it accounted for a 2.5% value share in the same year. When compared to the global level, the per capita consumption of meat remains high in Belgium in 2016. Hypermarkets & Supermarkets is the leading distribution channel in Belgium’s Meat sector, accounting for a total value share of 52.7% in 2016. Belgium offers limited growth potential to manufacturers of consumer...
-
Product Insights
Epidermolysis Bullosa Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H1, 2017" provides an overview of Epidermolysis Bullosa clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Global Confectionery Market: Merger and Acquisitions February 2016
Using this report, dealmakers will effectively gain an insight into deal activity of the canadean food market throughout the month. Additionally, the report provides an overview of all the partnering, alliances, and M&A deals announced worldwide. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of deal activity in the canadean food market on a monthly basis.
-
Product Insights
Epidermolysis Bullosa Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H1, 2016" provides an overview of Epidermolysis Bullosa clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Epidermolysis Bullosa Disease – Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H1, 2020" provides an overview of Epidermolysis Bullosa Clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...